Question 1

What are the key details for the project “Fosun Pharma GHP”?

Accepted Answer

The project “Fosun Pharma GHP” is an infrastructure initiative in the Waste Processing and Treatment sector, located in China. Taiyo aggregates data on it from International Finance Corporation (IFC).

Question 2

What is the latest status of the project “Fosun Pharma GHP”?

Accepted Answer

The status recorded for “Fosun Pharma GHP” is active.

Question 3

Who are the main government, EPC, and private stakeholders for “Fosun Pharma GHP”?

Accepted Answer

Taiyo maps the stakeholders of “Fosun Pharma GHP”: government bodies (International Finance Corporation (IFC)).

Question 4

What is the budget and commercial profile for the project “Fosun Pharma GHP”?

Accepted Answer

Taiyo normalizes the budget of “Fosun Pharma GHP” to USD 200000000.

Question 5

Where can I verify the source and access all details for “Fosun Pharma GHP”?

Accepted Answer

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/SII/45021/fosun-pharma-ghp). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	active
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	Shanghai Fosun Pharmaceutical (Group) Co. Ltd., (“Fosun Pharma”, or the “Company”) is a leading manufacturer of pharmaceutical products and medical devices in China. The Company’s business spans across the healthcare value chain from research & development, pharmaceutical manufacturing, medical devices and diagnosis, to healthcare services, pharmaceutical distribution and retail. Fosun Pharma has been listed on the Shanghai Stock Exchange since 1998 and Hong Kong Stock Exchange since 2012. The proposed IFC investment will primarily support Fosun Pharma’s manufacturing and distribution of COVID-19 related medical products, including the COVID-19 vaccine co-developed by Pfizer / BioNTech and COVID-19 testing kits and in China (the “Project”).
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Fosun Pharma GHP

Project Information FAQ

Project Information

More Waste Processing and Treatment projects in China